XML 76 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
Employee Benefit Plans (Tables)
9 Months Ended
Sep. 30, 2012
Employee Benefits and Share-based Compensation [Abstract]  
Schedule Of Stock Option Activity
Option Activity
Stock options activity during the nine months ended September 30, 2012, was as follows:
 
 
Options Outstanding
 
Number of shares
 
Weighted Average Exercise Price Per Share
 
(in thousands)
 
(in dollars)
December 31, 2011
3,950

 
$
27.03

Granted
1,272

 
33.81

Cancelled and expired
(313
)
 
30.34

Exercised
(472
)
 
22.79

September 30, 2012
4,437

 
$
29.19

Schedule Of RSU Activity
RSU Activity

RSU activity during the nine months ended September 30, 2012, was as follows:

 
RSUs Outstanding
 
Number of shares
 
Weighted Average Grant Date Fair Value Per Share
 
(in thousands)
 
(in dollars)
December 31, 2011
177

 
$
27.86

RSUs granted
50

 
31.64

RSUs vested
(103
)
 
29.19

RSUs cancelled
(9
)
 
30.59

September 30, 2012
115

 
$
28.10


Schedule Of Valuation And Expense Information
The following table sets forth the assumptions used to fair value option grants during the three and nine months ended September 30, 2012 and October 2, 2011 based on its historical experience.
 
 
Three Months Ended
 
Nine Months Ended
 
September 30,
2012
 
October 2,
2011
 
September 30,
2012
 
October 2,
2011
Expected life (in years)
4.4

 
4.3

 
 4.3 - 4.4
 
 4.3 - 4.4
Risk-free interest rate
0.48
%
 
1.09
%
 
0.48% - 0.91%
 
1.09% - 1.87%
Expected volatility
52.3
%
 
50.7
%
 
52.1% - 52.5%
 
49.9% - 50.7%
Dividend yield

 

 
 
Schedule Of Total Stock-Based Compensation Expense Resulting From Stock Options, Restricted Stock Awards, And The Employee Stock Purchase Plan
The following table sets forth the total stock-based compensation expense resulting from stock options, RSUs and the ESPP included in the Company’s unaudited condensed consolidated statements of operations (in thousands):
 
 
Three Months Ended
 
Nine Months Ended
 
September 30,
2012
 
October 2,
2011
 
September 30,
2012
 
October 2,
2011
Cost of revenue
$
473

 
$
259

 
$
1,021

 
$
737

Research and development
778

 
606

 
2,066

 
1,873

Sales and marketing
1,238

 
1,264

 
3,623

 
3,949

General and administrative
1,530

 
1,325

 
4,096

 
3,775

Total stock-based compensation
$
4,019

 
$
3,454

 
$
10,806

 
$
10,334